Scroll Back to Top

Study number 8530-848

Healthy & Overweight?


Jun 26 2024-Dec 20 2024


Daytona Beach, Florida




Male or Female




Cohort D2

Study Details

The investigational drug in this research study is being developed for the treatment of obesity.
The purposes of this study are to look at:
• How well the study drugs are tolerated and any side effects of the study drugs
• The effect of the study drugs on body weight
• How much of the study drug gets into the blood stream and how long it takes the body to get rid of it when given with tirzepatide. Tirzepatide is an investigational drug that has been approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management. The use of tirzepatide in this study is investigational.


Fortrea Daytona Beach, FL is recruiting for: 
- Healthy Overweight Men and Women, age 18-65 
- Body Mass Index between 27-45 
- Study involves multiple overnight stays & outpatient visits 
- Compensation up to $17,665 may be provided for time and participation 
- Refer a friend to receive $300 per qualified referral

Additional Details

Call Now To Schedule Your Screening Appointment! 


Cohort D2:

Check-In: Jun 26 
Check-Out: Jul 1

Check-In: Jul 4
Check-Out: Jul 5

Check-In: Jul 11
Check-Out: Jul 12

Check-In: Jul 18
Check-Out: Jul 19

Check-In: Jul 25
Check-Out: Jul 26

Check-In: Aug 1
Check-Out: Aug 2

Check-In: Aug 8
Check-Out: Aug 9

Check-In: Aug 15
Check-Out: Aug 16

Check-In: Aug 22
Check-Out: Aug 23

Check-In: Aug 29
Check-Out: Aug 30

Check-In: Sep 5
Check-Out: Sep 6

Check-In: Sep 12
Check-Out: Sep 13

Check-In: Sep 19
Check-Out: Sep 20

Check-In: Sep 26
Check-Out: Sep 27

Check-In: Oct 3
Check-Out: Oct 4

Check-In: Oct 10
Check-Out: Oct 14

Follow up Visits: Oct 25, Nov 8, 22, Dec 6, 20

BMI Calculator



Feet Inches